Patents by Inventor Barry Jiahao Liang

Barry Jiahao Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photo-immunoconjugate Formulations and Methods of Treatment Relating Thereto
    Publication number: 20240108724
    Abstract: The present disclosure relates to photo-immunoconjugate formulations comprising a nanoparticle carrier comprising first and second therapeutic agents coupled to the nanoparticle carrier, and a photosensitizer molecule coupled to the first therapeutic agent or the nanoparticle carrier, and methods of treating cancer via administration of the photo-immunoconjugate formulations.
    Type: Application
    Filed: June 29, 2023
    Publication date: April 4, 2024
    Applicant: University of Maryland, College Park
    Inventors: Huang-Chiao Huang, Barry Jiahao Liang
  • Photo-immunoconjugate formulations and methods of treatment relating thereto
    Patent number: 11759521
    Abstract: The present disclosure relates to photo-immunoconjugate formulations comprising a nanoparticle carrier comprising first and second therapeutic agents coupled to the nanoparticle carrier, and a photosensitizer molecule coupled to the first therapeutic agent or the nanoparticle carrier, and methods of treating cancer via administration of the photo-immunoconjugate formulations.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: September 19, 2023
    Inventors: Huang-Chiao Huang, Barry Jiahao Liang
  • Photo-immunoconjugate Formulations and Methods of Treatment Relating Thereto
    Publication number: 20200368354
    Abstract: The present disclosure relates to photo-immunoconjugate formulations comprising a nanoparticle carrier comprising first and second therapeutic agents coupled to the nanoparticle carrier, and a photosensitizer molecule coupled to the first therapeutic agent or the nanoparticle carrier, and methods of treating cancer via administration of the photo-immunoconjugate formulations.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 26, 2020
    Applicant: University of Maryland, College Park
    Inventors: Huang-Chiao Huang, Barry Jiahao Liang